The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial.

Complementary therapies in clinical practice
Q1
May 2022
Citations:13
Influential Citations:2
Interventional (Human) Studies
82
S2 Icon

Abstract

No abstract available